Not applicableEnded earlyNCT04642690What this trial is testingNitrates and IL-8 in Barrett's EsophagusWho this might be right forBarrett EsophagusEsophageal Adenocarcinoma Mayo Clinic 9
Not applicableEnrolling By InvitationNCT07212491What this trial is testingMinimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal AdenocarcinomaWho this might be right forBarrett EsophagusEsophageal Adenocarcinoma Mayo Clinic 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT06628310What this trial is testingEvaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaWho this might be right forLocally Advanced Unresectable or Metastatic Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma AbbVie 185
Early research (Phase 1)Ended earlyNCT04144140What this trial is testingStudy of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101Who this might be right forLymphomaAdvanced Solid Tumors Eisai Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07000253What this trial is testingTiming of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaWho this might be right forEsophageal CancerGastric (Stomach) CancerGastric Adenocarcinoma+3 more Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 290
Early research (Phase 1)Study completedNCT00004257What this trial is testingOxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach CancerWho this might be right forEsophageal Cancer Albany Medical College
Not applicableStudy completedNCT01635595What this trial is testingNodal Status in Adenocarcinoma of the Esophagus an CardiaWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastric Cardia University of Bologna 194
Testing effectiveness (Phase 2)Looking for participantsNCT07282912What this trial is testingTrial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) LevelsWho this might be right forForegut AdenocarcinomaEsophageal AdenocarcinomaGastroesophageal Adenocarcinoma+6 more Yale University 54
Testing effectiveness (Phase 2)Study completedNCT00077545What this trial is testing3-AP Plus Cisplatin in Treating Patients With Recurrent or Metastatic Adenocarcinoma of the Esophagus or Gastroesophageal JunctionWho this might be right forAdenocarcinoma of the EsophagusRecurrent Esophageal CancerStage IV Esophageal Cancer National Cancer Institute (NCI) 39
Large-scale testing (Phase 3)Study completedNCT00487695What this trial is testingConfocal Endomicroscopy for Barrett's EsophagusWho this might be right forBarrett's EsophagusEsophageal Adenocarcinoma Johns Hopkins University 46
Not applicableEnded earlyNCT04077372What this trial is testingAssessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal CancersWho this might be right forGastrointestinal CancerColorectal CancerPancreatic Adenocarcinoma+6 more Stanford University 12
Not applicableStudy completedNCT03529968What this trial is testingSiewert Type I-II: CT, PET-CT, EUS Sensitivity/Specificity for the Assessment of Lymph Node MetastasesWho this might be right forSiewert Type I-II Adenocarcinoma of the Esophagus University of Bologna 101
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 680
Testing effectiveness (Phase 2)Ended earlyNCT00003487What this trial is testingAntineoplaston Therapy in Treating Patients With Cancer of the EsophagusWho this might be right forAdenocarcinoma of the Esophagus Burzynski Research Institute 8
Early research (Phase 1)Study completedNCT00537121What this trial is testingVorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal CancerWho this might be right forEsophageal CancerGastric CancerLiver Cancer Roswell Park Cancer Institute 23
Not applicableStudy completedNCT02130011What this trial is testingDose-Guided Radiotherapy in Oesophageal Cancer: Managing the Real DoseWho this might be right forAdenocarcinoma Maastricht Radiation Oncology 20
Testing effectiveness (Phase 2)Study completedNCT00045526What this trial is testingErlotinib Hydrochloride in Treating Patients With Advanced Esophageal Cancer or Stomach CancerWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionRecurrent Esophageal Cancer+3 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT06445972What this trial is testingSubstudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Who this might be right forGastroesophageal JunctionGastroesophageal AdenocarcinomaEsophageal Neoplasms+1 more Merck Sharp & Dohme LLC 210
Testing effectiveness (Phase 2)WithdrawnNCT06967987What this trial is testingStudy Evaluating the Combination of Bemarituzumab + FLOT Chemotherapy in Perioperative Setting for Resectable Stage cT2-T4a or N+ Gastric and GEJ Adenocarcinoma Overexpressing FGFR2bWho this might be right forGastric and Gastro-oesophageal Junction (GEJ) AdenocarcinomasOverexpression FGFR2b Institut Cancerologie de l'Ouest
Testing effectiveness (Phase 2)Study completedNCT00005599What this trial is testingBryostatin 1 Plus Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer or Stomach CancerWho this might be right forEsophageal CancerGastric Cancer Memorial Sloan Kettering Cancer Center